SCHEMBL8197935

SCHEMBL8197935

Fc1ccc(-c2ccccc2C2=NCCN2)cc1

nearest known ligand 0.75

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 16/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8194068 0.85 NISCH (0.77) NISCH
SCHEMBL9579892 0.84 NISCH (0.81) NISCH
SCHEMBL8202723 0.83 NISCH (0.75) NISCH
SCHEMBL8189633 0.83 NISCH (0.71) NISCH
SCHEMBL8204316 0.83 NISCH (0.74) NISCH
SCHEMBL771337 0.82 NISCH (0.66) NISCH
SCHEMBL8197880 0.80 NISCH (0.69) NISCH
SCHEMBL8189601 0.80 NISCH (0.49) NISCH
SCHEMBL8202988 0.80 NISCH (0.71) NISCH
SCHEMBL8200536 0.80 NISCH (0.71) NISCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000078726-A1 IMIDAZOLINE DERIVATIVES FOR THE TREATMENT OF DIABETES, ESPECIALLY TYPE II DIABETES ELI LILLY AND COMPANY (US) 2000-12-28 WO disclosed